Preoperative CA-125 in low-grade endometrial cancer: risk stratification and implications for treatment.
作者信息
Kwon Janice S
机构信息
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada.
出版信息
J Gynecol Oncol. 2019 Sep;30(5):e92. doi: 10.3802/jgo.2019.30.e92.
Abstract
摘要
相似文献
1
Preoperative CA-125 in low-grade endometrial cancer: risk stratification and implications for treatment.低级别子宫内膜癌的术前CA-125：风险分层及其对治疗的意义
J Gynecol Oncol. 2019 Sep;30(5):e92. doi: 10.3802/jgo.2019.30.e92.
2
Novel algorithm including CA-125, HE4 and body mass index in the diagnosis of endometrial cancer.包括CA - 125、HE4和体重指数的新型算法在子宫内膜癌诊断中的应用
Gynecol Oncol. 2017 Oct;147(1):126-132. doi: 10.1016/j.ygyno.2017.07.130. Epub 2017 Jul 21.
3
Preoperative CA 125 in endometrial cancer: is it useful?
Am J Obstet Gynecol. 2000 Jun;182(6):1328-34. doi: 10.1067/mob.2000.106251.
4
Serum CA 125 levels and lymph node metastasis in patients with endometrial cancer.子宫内膜癌患者的血清CA 125水平与淋巴结转移
Wien Klin Wochenschr. 2006;118 Suppl 2:62-5. doi: 10.1007/s00508-006-0554-9.
5
Preoperative Pelvic MRI and Serum Cancer Antigen-125: Selecting Women With Grade 1 Endometrial Cancer for Lymphadenectomy.术前盆腔磁共振成像及血清癌抗原125：筛选1级子宫内膜癌患者进行淋巴结清扫术
AJR Am J Roentgenol. 2015 Nov;205(5):W556-64. doi: 10.2214/AJR.14.13746.
6
Preoperative serum CA-125 levels in treating endometrial cancer.子宫内膜癌治疗中的术前血清CA-125水平。
J Reprod Med. 2005 Aug;50(8):585-90.
7
Predicting Model of Lymph Node Metastasis Using Preoperative Tumor Grade, Transvaginal Ultrasound, and Serum CA-125 Level in Patients With Endometrial Cancer.利用术前肿瘤分级、经阴道超声及血清CA-125水平预测子宫内膜癌患者淋巴结转移的模型
Int J Gynecol Cancer. 2016 Nov;26(9):1630-1635. doi: 10.1097/IGC.0000000000000820.
8
HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET).HE4 和 CA125 水平在子宫内膜癌患者术前评估中的应用：一项前瞻性多中心研究（ENDOMET）。
Acta Obstet Gynecol Scand. 2013 Nov;92(11):1313-22. doi: 10.1111/aogs.12235.
9
Importance of Preoperative Knowledge of the Biomarker HE4 in Early-stage Endometrial Cancer Regarding Surgical Management.术前了解生物标志物人附睾蛋白4在早期子宫内膜癌手术治疗中的重要性。
Anticancer Res. 2017 May;37(5):2697-2702. doi: 10.21873/anticanres.11619.
10
Preoperative assessment in endometrial cancer. Is triage for lymphadenectomy possible?子宫内膜癌的术前评估。淋巴结切除术的分诊是否可行？
J BUON. 2017 Jan-Feb;22(1):34-43.
引用本文的文献
1
Heart transplantation and biomarkers: a review about their usefulness in clinical practice.心脏移植与生物标志物：关于其在临床实践中效用的综述
Front Cardiovasc Med. 2024 Jan 24;11:1336011. doi: 10.3389/fcvm.2024.1336011. eCollection 2024.
2
The value of serum HE4 and CA125 levels for monitoring the recurrence and risk stratification of endometrial endometrioid carcinoma.血清HE4和CA125水平在监测子宫内膜样腺癌复发及风险分层中的价值。
Heliyon. 2023 Jul 8;9(7):e18016. doi: 10.1016/j.heliyon.2023.e18016. eCollection 2023 Jul.
本文引用的文献
1
Improved preoperative risk stratification with CA-125 in low-grade endometrial cancer: a multicenter prospective cohort study.CA-125 改善低级别子宫内膜癌的术前风险分层：一项多中心前瞻性队列研究。
J Gynecol Oncol. 2019 Sep;30(5):e70. doi: 10.3802/jgo.2019.30.e70.
2
Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment.全球归因于糖尿病和高体重指数的癌症负担：一项比较风险评估。
Lancet Diabetes Endocrinol. 2018 Jun;6(6):e6-e15. doi: 10.1016/S2213-8587(18)30150-5.
3
Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease.前哨淋巴结定位算法与根治性淋巴结清扫术在检测具有较高淋巴结转移风险的IIIC期子宫内膜癌中的比较。
Gynecol Oncol. 2017 Dec;147(3):541-548. doi: 10.1016/j.ygyno.2017.09.030. Epub 2017 Sep 29.
4
L1CAM expression in endometrial carcinomas: an ENITEC collaboration study.子宫内膜癌中L1细胞粘附分子的表达：一项欧洲肿瘤内科学会合作研究
Br J Cancer. 2016 Sep 6;115(6):716-24. doi: 10.1038/bjc.2016.235. Epub 2016 Aug 9.
5
Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion.子宫内膜样子宫内膜癌且肌层浸润有限患者中前哨淋巴结与选择性淋巴结清扫术算法的比较。
Gynecol Oncol. 2016 Mar;140(3):394-9. doi: 10.1016/j.ygyno.2015.12.028. Epub 2015 Dec 31.
6
L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation.L1CAM 在早期 I 型子宫内膜癌中的表达：一项大型多中心评估的结果。
J Natl Cancer Inst. 2013 Aug 7;105(15):1142-50. doi: 10.1093/jnci/djt144. Epub 2013 Jun 18.
7
Integrated genomic characterization of endometrial carcinoma.子宫内膜癌的综合基因组特征分析。
Nature. 2013 May 2;497(7447):67-73. doi: 10.1038/nature12113.
8
Preoperative serum CA 125 level in the prediction of the stage of disease in endometrial carcinoma.术前血清 CA125 水平在子宫内膜癌疾病分期预测中的价值。
Eur J Obstet Gynecol Reprod Biol. 2012 Oct;164(2):191-5. doi: 10.1016/j.ejogrb.2012.05.038. Epub 2012 Jun 22.
9
The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer.血清 CA-125 在预测明显早期子宫内膜癌的子宫外疾病中的效用。
Int J Cancer. 2012 Aug 15;131(4):885-90. doi: 10.1002/ijc.26433. Epub 2011 Nov 19.
10
Can a preoperative CA 125 level be a criterion for full pelvic lymphadenectomy in surgical staging of endometrial cancer?术前CA 125水平能否作为子宫内膜癌手术分期中全盆腔淋巴结清扫术的标准？
Gynecol Oncol. 2002 Jul;86(1):28-33. doi: 10.1006/gyno.2002.6664.
Zotero 插件